CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
SelfPOCNAD aims to develop a rapid cervical cancer screening prototype using self-collected samples. This technology will enhance compliance with screening programs, potentially reducing the incidence of cervical cancer and saving lives by facilitating earlier detection.
In SelfPOCNAD, we propose to develop an industrial prototype for a rapid (“same day”) Cervical Cancer screening of self-taken patient samples.
The industrial prototype will only include enough sample from the self-taken sample in order not to risk any clogging of the sample preparation chip.
The first industrial prototype will include the detection of oncogenic E6/E7 mRNA from in total 9 HPV types with an option to detect up to 19 HPV types based on detection developed for Pre-Tect HPV-Proofer l…
NORCHIP AS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, ALMELO
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Spain, Mondragon
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
